In February 2023, she received a revolutionary stem cell therapy. Doctors transplanted labor-grown islet cells into her body, and within a few months, she no longer needed to rely on external insulin.

Induced Pluripotent Stem Cells: Some genes (originally Oct3/4, Soc2, c-Myc and Klf4) are introduced into ordinary body cells such as skin through a retroviral vector, and they are "initialized" to enable them to function as stem cells. These are "iPSCs".

CDE interprets the "Guidelines for Adaptive Design of Drug Clinical Trials (Trial Implementation)"

In August 2024, the Beijing City Semi-annual Working Conference on Drug Regulation was held, and it was particularly affirmed that the work of issuing the country's first stem cell "Drug Production License" was carried out.

As an important clinical treatment and scientific research tool, induced pluripotent stem cells (iPSC) have shown huge application potential.

The results of this study demonstrate the feasibility and adequacy of inducing skin cells derived from patients with late-onset Alzheimer's disease to transform into neurons in a 3D environment.

As the core technology of the third medical revolution, stem cell technology is promoting profound changes in the medical field.

The conclusions of on-site inspections of clinical trials in the United States are divided into: OAI: "Serious problems require official administrative measures".